PARSIPPANY, N.J.--(BUSINESS WIRE)--May 20, 2015--
Pacira
Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that Dave
Stack, president, chief executive officer and chairman of Pacira
Pharmaceuticals, is scheduled to present an overview of the company at
the following investor conferences in June:
-
Jefferies 2015 Global Healthcare Conference at 11:30 a.m. ET in New
York on Monday, June 1, 2015.
-
Goldman Sachs 36th Annual Global Healthcare Conference at
10:40 a.m. PT in Rancho Palos Verdes, California on Tuesday, June 9,
2015.
Live audio webcasts of the Pacira presentations can be accessed by
visiting the “Investors & Media” section of the company’s website at
investor.pacira.com. Replays of the webcasts will be archived on the
Pacira website for two weeks following the respective presentation dates.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s flagship product,
EXPAREL® (bupivacaine liposome injectable suspension), indicated for
single-dose infiltration into the surgical site to produce postsurgical
analgesia, was commercially launched in the United States in April 2012.
EXPAREL and two other products have successfully utilized DepoFoam®, a
unique and proprietary product delivery technology that encapsulates
drugs without altering their molecular structure, and releases them over
a desired period of time. Additional information about Pacira is
available at www.pacira.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150520005815/en/
Source: Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc.
Jessica Cho, 973-254-3574
